Loading...
XNAS
BNKK
Market cap6mUSD
Dec 05, Last price  
0.20USD
1D
-1.20%
1Q
-48.93%
IPO
-96.71%
Name

Jupiter Wellness Inc

Chart & Performance

D1W1MN
XNAS:BNKK chart
P/E
P/S
9.13
EPS
Div Yield, %
Shrs. gr., 5y
47.39%
Rev. gr., 5y
155.44%
Revenues
702k
+246.36%
6,4551,065,6652,876,2736,196,743202,670701,967
Net income
-49m
L+227.58%
-932,019-6,406,007-29,836,351-17,671,484-15,083,041-49,409,632
CFO
-19m
L+88.73%
-692,740-2,732,736-7,567,645-6,395,942-10,113,777-19,087,550

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
IPO date
Oct 22, 2020
Employees
10
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT